The paradoxical psychological effects of lysergic acid diethylamide (LSD)
Robin Carhart-Harris, Mendel Kaelen, Mark Bolstridge, Tom A. Williams, Lindsey Williams, Raphael Underwood, Amanda Feilding, David Nutt
Psychological Medicine February 5, 2016 DOI: 10.1017/s0033291715002901 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Within-subjects controlled trial Peer reviewed |
|---|---|
| Sample size | 20 |
| Population | Healthy volunteers |
| Intervention | LSD |
| Dose | 75 µg, intravenously |
| Duration | 2-week follow-up after each session |
| Topics | LSD Mescaline Psilocybin |
| Keywords | Hallucinogen Mood Cognition Clinical psychology Psychosis Placebo |
| Citations | 301 |
| Key findings | LSD acutely produced heightened mood and psychosis-like symptoms, yet two weeks later increased optimism and trait openness without changes in delusional thinking. |
Abstract
Background: Lysergic acid diethylamide (LSD) is a potent serotonergic hallucinogen or psychedelic that modulates consciousness in a marked and novel way. This study sought to examine the acute and mid-term psychological effects of LSD in a controlled study.
Method: A total of 20 healthy volunteers participated in this within-subjects study. Participants received LSD (75 µ g, intravenously) on one occasion and placebo (saline, intravenously) on another, in a balanced order, with at least 2 weeks separating sessions. Acute subjective effects were measured using the Altered States of Consciousness questionnaire and the Psychotomimetic States Inventory (PSI). A measure of optimism (the Revised Life Orientation Test), the Revised NEO Personality Inventory, and the Peter's Delusions Inventory were issued at baseline and 2 weeks after each session.
Results: LSD produced robust psychological effects; including heightened mood but also high scores on the PSI, an index of psychosis-like symptoms. Increased optimism and trait openness were observed 2 weeks after LSD (and not placebo) and there were no changes in delusional thinking.
Conclusions: The present findings reinforce the view that psychedelics elicit psychosis-like symptoms acutely yet improve psychological wellbeing in the mid to long term. It is proposed that acute alterations in mood are secondary to a more fundamental modulation in the quality of cognition, and that increased cognitive flexibility subsequent to serotonin 2A receptor (5-HT 2A R) stimulation promotes emotional lability during intoxication and leaves a residue of ‘loosened cognition’ in the mid to long term that is conducive to improved psychological wellbeing.
Comparable studies
Other non-randomized and open-label trials on LSD, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Study of Lysergic Acid Diethylamide as an Analgesic Agent Hospital patients | 1964 | Clinical trial | n = 50 |
| Localization of serotonin 5‐HT2 receptors in living human brain by positron emission tomography using N1‐([11C]‐methyl)‐2‐BR‐LSD Normal human volunteers | 1987 | Clinical trial | n = 7 |
| Psychedelic Therapy Utilizing LSD in the Treatment of the Alcoholic Patient: A Preliminary Report Alcoholic patients | 1967 | Pilot study | n = 69 |
| LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study Patients with LSD-induced hallucinogen persisting perception disorder (HPPD) | 2000 | Open-label pilot study | n = 8 |
| DOET(2,5-Dimethoxy-4-Ethylamphetamine), a New Psychotropic Drug Normal male subjects | 1971 | Controlled trial |
Citations in the library
Cited by 241
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics Pharmacological Reviews June 20, 2019
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
- Psychedelics and the essential importance of context. Journal of Psychopharmacology February 15, 2018
- Global Street Food: la cocina de la calle Diseño interior 2009
and 236 more in the library
Cites 48
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Archives of General Psychiatry August 1, 2006
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
and 43 more in the library